Pharma, Exploitation, and Poor Communities
Bloomsbury Academic (Verlag)
979-8-216-27774-3 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
Multinational pharmaceutical companies and research funding institutions from high-income countries frequently sponsor clinical trials in low- and middle-income countries, where underdeveloped health and welfare systems raise significant ethical concerns. The power asymmetry between well-resourced foreign sponsors and local communities with limited bargaining power further amplifies concerns of unjust treatment and fears of exploitation.
By drawing upon arguments from health research ethics; political philosophy, particularly global distributive justice; and the literature on the principle of fair play, this book addresses a significant gap in the current discourse: the lack of a solid conceptual foundation for the claim that host communities are entitled to fair benefits. Felicitas Holzer discusses concerns related to structural injustice and proposes alternative mechanisms to secure fair benefits for host communities. Ultimately, Holzer argues that obligations of fair benefit-sharing arise from the requirements of fair cooperation between distinct stakeholders.
Felicitas Sofia Holzer is Postdoctoral Fellow at University of Zurich, Switzerland
Acknowledgements
SETTING THE STAGE
1. International Health Research and Poor Communities
TRANSACTIONS
2. From the “Double Standard” to “Fair Benefits”, “Community Exploitation”, and the “Social Value Requirement”
3. Transactional Models for Fair Benefit-sharing: Three Fundamental Objections
FAIR PLAY
4. Fair Benefit-Sharing and Community Exploitation under the Fair Play Model: Reply to Fundamental Objection (i)
5. Cosmopolitanism and the Extension of Fair Benefit-Sharing to Other Agents
6. The Fair Play Model and Non-Ideal Theory: Accounting for Structural Injustice within a Theory of Exploitation: Reply to Fundamental Objection (ii)
7. Principles, Procedures, and Mechanisms for Safeguarding Fair Benefits: Reply to Fundamental Objection (iii)
RESULTS & CONCLUSION
8. Discussion
Bibliography
Index
| Erscheint lt. Verlag | 17.9.2026 |
|---|---|
| Reihe/Serie | Revolutionary Bioethics |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Geisteswissenschaften ► Philosophie ► Ethik |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik | |
| Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin | |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| Sozialwissenschaften ► Soziologie | |
| ISBN-13 | 979-8-216-27774-3 / 9798216277743 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
